Emulate

Boston, MA · Founded 2013 · Privately Held (backing)

Developer of organ-on-a-chip technology designed to predict human response with greater precision and detail than other experimental testing methods. Emulate is based in Boston, MA and was founded in 2013. It was valued at $140 million at its later-stage round in Mar 2024, the last priced event on record. It has raised $278 million across 7 recorded rounds; the latest was a $57.5 million later-stage round in Aug 2021.

PMV mark · valuation
$140.0M
Oct 2026
Priced at
its later-stage round
Mar 2024
Total raised
$278.4M
Last round
Later Stage VC
Aug 2021
What is Emulate worth?
$140.0MPrivateMarketView mark · Oct 2026

Valued at $140.0M at its later-stage round, Mar 2024. Nothing has traded since.

Free account
More of Emulate with a free account
  • ·The complete investor list: 33 names
  • ·Watch Emulate: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Emulate funding history

7 rounds
DateRoundRaisedPost-money
Aug 2021Later Stage VC$57.5M▮
Mar 2020Debt$19.3M▮
Aug 2019Early Stage VC$28.0M▮
Jun 2018Early Stage VC$36.0M▮
Oct 2017Seed Round$746K▮
Mar 2016Early Stage VC$28.8M▮
+ 1 earlier rounds · a free account shows the full history
Unlock post-money valuations

Membership and data by Private Market View

Emulate valuation

Emulate was valued at $140 million at its later-stage round in Mar 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Emulate raised?

Emulate has raised $278 million across 7 recorded rounds since 2014. The largest was a $745,750 seed round in Oct 2017; the most recent was a $57.5 million later-stage round in Aug 2021.

Emulate has filed 7 Form Ds with the SEC since 2014, most recently in Sep 2021 ($57.5 million sold to 7 investors).

How Emulate's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Emulate, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Emulate

What is Emulate worth?
Emulate is valued at $140.0M as of Oct 2026. Valued at $140.0M at its later-stage round, Mar 2024. Nothing has traded since.
How much has Emulate raised?
Emulate has raised $278.4M in total funding across 7 recorded rounds.
When did Emulate last raise?
Emulate last raised in Aug 2021 (Later Stage VC), raising $57.5M.